ST. LOUIS -- As the leading cause of death in the western world, congestive heart failure is on the top of many Americans' minds. Theodosios Alexander, Sc.D. (a.k.a. Theodosios Korakianitis), Dean of Parks College of Engineering, Aviation and Technology at Saint Louis University, has dedicated aspects of his research to changing the way that engineers and doctors think about the treatment of the debilitating disease.
|Theodosios Alexander, Sc.D.|
A special community presentation on the subject will take place at 2 p.m. Saturday, Feb. 16, at the University's Il Monastero, 3050 Olive (east of Compton). The event is free and open to the public, however registration is requested. Parking is available on the lot adjoining the building.
Dean Alexander will address, in lay-person's terms, the development of mechanical circulatory support devices. These are pumps designed to prolong the lives of patients suffering from congestive heart failure. He also will review the human heart as a pumping system and discuss his optimal design of the next generation of mechanical circulatory support devices.
Alexander's two devices are designed to address different stages of the disease and are currently under development, the first in London and the second at SLU. Both devices are designed to be installed with minimally invasive surgery and not attached to the heart, unlike current ventricular assist devices (VADs).
The presentation will be followed by a reception, where individuals can speak with Dean Alexander about his life-changing research.
Alexander has been awarded the Inventor of the Year Award by the UK National Health Service Innovations Program for his personal research on mechanical circulatory support devices, and actively pursues the development and commercialization of these devices in London and now in St. Louis.
His work is a paradigm shift in cardiac assist devices promising to change medical practices in the field. The outcome of this research has enormous implications for the quality of life of patients, for their caregivers, and financial advantages for the long-term provision of medical care to these patients.